Showing results (171-180 of 258) with videos related to
Sort By:
Pageof 26
Plos One|August 13, 2013
Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trialGeorge Fountzilas, Vassiliki Kotoula, Dimitrios Pectasides, et al.BMC Medicine|January 9, 2010
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group studyDimitrios Bafaloukos, Helena Linardou, Gerasimos Aravantinos, et al.BMC Clinical Pathology|July 3, 2014
alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studiesTriantafyllia Koletsa, Flora Stavridi, Mattheos Bobos, et al.Breast Cancer Research and Treatment|March 11, 2011
Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) studyGeorge Pentheroudakis, Anna Batistatou, Konstantine T Kalogeras, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanomaDimitrios Pectasides, Urania Dafni, Dimitrios Bafaloukos, et al.Pathology Oncology Research : POR|August 8, 2014
p85 protein expression is associated with poor survival in HER2-positive patients with advanced breast cancer treated with trastuzumabKitty Pavlakis, Mattheos Bobos, Anna Batistatou, et al.Acta Oncologica (Stockholm, Sweden)|May 18, 2021
AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group studyGeorge Zarkavelis, Epaminontas Samantas, Georgia-Angeliki Koliou, et al.Breast Cancer Research and Treatment|August 1, 2008
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trialGeorge Pentheroudakis, Konstantine T Kalogeras, Ralph M Wirtz, et al.Clinical Breast Cancer|January 22, 2016
Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer PatientsVasilios Karavasilis, Christos Papadimitriou, Helen Gogas, et al.Human Pathology|November 8, 2020
Genotype-phenotype associations in colorectal adenocarcinomas and their matched metastasesKyriakos Chatzopoulos, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.Pageof 26